CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Psychopharmacology

• Publication date

  2011-02-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00213-011-2224-5PMID 21340468PMCID PMC3606913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Spinal Neurotransmitter Receptors in Itch: New Insights into Therapies and Drug Development

  2011cited by this paper
• Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks.

  2010cited by this paper
• Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.

  2010cited by this paper
• Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization

  2010cited by this paper
• Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats

  2009cited by this paper
• Cellular Basis of Itch Sensation

  2009influential reference
• The influence of ACEA--a selective cannabinoid CB1 receptor agonist on whole blood and platelet-poor plasma serotonin concentrations.

  2009cited by this paper
• Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus

  2009cited by this paper
• Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.

  2008cited by this paper
• Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.

  2008cited by this paper
• Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain

  2008cited by this paper
• Peripheral cannabinoid CB1 receptors inhibit evoked responses of nociceptive neurones in vivo.

  2008cited by this paper
• Serotonin Evokes Endocannabinoid Release and Retrogradely Suppresses Excitatory Synapses

  2008cited by this paper
• Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System

  2007cited by this paper
• Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats

  2007cited by this paper
• Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study

  2007cited by this paper
• Noxious heat and scratching decrease histamine-induced itch and skin blood flow.

  2005cited by this paper
• The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

  2003cited by this paper
• Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin

  2003cited by this paper
• Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats

  2003cited by this paper
• Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.

  2003cited by this paper
• Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80.

  2002cited by this paper
• Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.

  2002cited by this paper
• Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.

  2001cited by this paper
• Inhibitory effects of SR141716A on G-protein activation in rat brain.

  2001cited by this paper
• Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced β-hexosaminidase, serotonin and TNFα release from rat RBL-2H3 basophilic leukaemia cells

  2001cited by this paper
• Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch

  2001cited by this paper
• Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice

  2000influential reference
• In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments

  2000cited by this paper
• CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.

  1998cited by this paper
• Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.

  1998cited by this paper
• CB1 Receptor Antagonist Precipitates Withdrawal in Mice Exposed to Δ9-Tetrahydrocannabinol

  1998cited by this paper
• Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice.

  1998cited by this paper
• Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

  1998cited by this paper
• SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.

  1997cited by this paper
• A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain

  1996cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994influential reference
• C-kit gene is expressed by skin mast cells in embryos but not in puppies of Wsh/Wsh mice: age-dependent abolishment of c-kit gene expression.

  1994influential reference
• Effect of multiple applications of compound 48/80 on mast cells of rat conjunctiva

  1987cited by this paper
• Effects of prolonged treatment with compound 48/80 on the gastric mucosa and mast cells in the rat.

  1985cited by this paper
• Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat.

  1985cited by this paper
• Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level.

  1983cited by this paper
• CHANGES IN BODY TEMPERATURE AND OXYGEN CONSUMPTION RATE OF CONSCIOUS MICE PRODUCED BY INTRAHYPOTHALAMIC AND INTRACEREBROVENTRICULAR INJECTIONS OF Δ9‐TETRAHYDROCANNABINOL

  1982cited by this paper
• Effect of Δ9-tetrahydrocannabinol on hypothalamic thermosensitive units

  1980cited by this paper
• Effect of delta 9-tetrahydrocannabinol on hypothalamic thermosensitive units.

  1980cited by this paper
• Morphine‐like ligand for opiate receptors in human CSF

  1975cited by this paper
• Effect of cromolyn sodium and of daily exposure to compound 48/80 on experimental asthma.

  1975cited by this paper

• Anti-inflammatory and analgesic potential of minor cannabinoids in vivo.

  2026cites this paper
• The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB2 receptor activation.

  2024cites this paper
• Attenuation of 1-chloro-2,4-dinitrobenzene-induced inflammation in atopic dermatitis-like skin lesions in rats by a pyrrole containing FELL-NH 2 bioconjugate: Cannabinoid receptor type 1 involvement

  2024cites this paper
• The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment

  2023cites this paper
• A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence

  2023cites this paper
• Cannabis as a Source of Approved Drugs: A New Look at an Old Problem

  2023cites this paper
• Early onset female pattern hair loss: A case-control study for analyzing clinical features and genetic variants.

  2022cites this paper
• Electroacupuncture reduces chronic itch via cannabinoid CB1 receptors in the ventrolateral periaqueductal gray

  2022cites this paper
• Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects

  2022cites this paper
• PARTICIPATION OF CANNABINOID RECEPTORS IN ANTIPRURITIC ACTIVITY INDUCED BY SYSTEMIC DIPYRONE IN MICE

  2022cites this paper
• Neuropathic itch treated with oral cannabinoids: A case series

  2021cites this paper
• Cannabis and the skin.

  2021cites this paper
• Pharmacological characterization of a rat Nav1.7 loss-of-function model with insensitivity to pain.

  2020cites this paper
• Cannabinoids for the Treatment of Chronic Pruritus: A Review.

  2020cites this paper
• Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases

  2020cites this paper
• Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist

  2020cites this paper
• Advances in Understanding the Initial Steps of Pruritoceptive Itch: How the Itch Hits the Switch

  2020cites this paper
• A Review of Cannabis in Chronic Kidney Disease Symptom Management

  2019cites this paper
• SYSTEMIC CANNABIDIOL DOES NOT REDUCE COMPOUND 48/80-INDUCED ITCHING BEHAVIOR IN MICE

  2019cites this paper
• Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212‐2, a cannabinoid receptor agonist

  2018cites this paper
• Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.

  2018cites this paper
• THE OFFICIAL JOURNAL OF TRAKYA UNIVERSITY FACULTY OF MEDICINE

  2018cites this paper
• Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD.

  2017cites this paper
• Effects of propofol on CB 1 receptor expression in spinal cord of rats with intrathecal morphine-induced pruritus

  2016cites this paper
• Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice

  2016cites this paper
• Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids*

  2016cites this paper
• Chapter 2 – Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents

  2016cites this paper
• Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase

  2015cites this paper
• Evaluation of sex differences in cannabinoid dependence.

  2014cites this paper
• Oleoylethanolamide: A Novel Potential Pharmacological Alternative to Cannabinoid Antagonists for the Control of Appetite

  2014cites this paper
• TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation

  2014cites this paper
• Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats

  2013influential citation
• BEHAVIORAL PHARMACOLOGY OF CANNABINOIDS: TOWARDS AN ANIMAL MODEL FOR STUDYING

  2013influential citation
• Analysis of Tolerance and Behavioral/Physical Dependence during Chronic CB1 Agonist Treatment: Effects of CB1 Agonists, Antagonists, and Noncannabinoid Drugs

  2013cites this paper
• Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity

  2012cites this paper
• BEHAVIORAL PHARMACOLOGY OF CANNABINOIDS: TOWARDS AN ANIMAL MODEL FOR STUDYING CANNABINOID DEPENDENCE/WITHDRAWAL

  2012cites this paper